EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Normalisation of the bone scan with continuous long-term alendronate therapy for Pagets disease of bone A true remmision?



Normalisation of the bone scan with continuous long-term alendronate therapy for Pagets disease of bone A true remmision?



Calcified Tissue International 64(SUPPL 1): S95




(PDF emailed within 1 workday: $29.90)

Accession: 035405036

Download citation: RISBibTeXText



Related references

Continuous long-term alendronate therapy for Pagets disease of bone Can we effect a cure?. Calcified Tissue International 64(SUPPL 1): S95, 1999

Use of bone marrow scan and bone scan in evaluating pagets disease of bone. Orthopaedic Transactions 3(3): 376-377, 1979

Long term therapy of pagets disease of bone with ethane 1 hydroxy 1 1 di phosphonate. Arthritis & Rheumatism: 1177-1184, 1980

Hyper parathyroidism secondary to long term therapy of pagets disease of bone with calcitonin. Talmage, Roy V And Paul L Munson (Ed ) Excerpta Medica International Congress Series, No 243 Calcium, Parathyroid Hormone And The Calcitonins Proceedings Of The 4th Parathyroid Conference Chapel Hill, N C , U S A , March 15-19, 1971 560p Illus Excerpta Medica: Amsterdam, The Netherlands 113-115, 1972

Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapy. Osteoporosis International 25(12): 2709-2719, 2015

Identification of Pagets disease specific genes by differential display PCR in whole bone explants and long term bone marrow cultures. Bone (New York) 17(6): 587, 1995

Pagets disease of bone clinical assessment present and future therapy symposium on the treatment of pagets disease of bone new york new york usa october 20 1989. Singer, F R And S Wallach Paget's Disease Of Bone: Clinical Assessment, Present And Future Therapy; Symposium on The Treatment Of Paget's Disease Of Bone, New York, New York, Usa, October 20, 1989 Xxi+313p Elsevier Science Publishing Co , Inc : New York, New York, Usa; Amsterdam, Netherlands Illus Xxi+313p, 1991

Discontinuation of alendronate and administration of bone-forming agents after surgical nailing may promote union of atypical femoral fractures in patients on long-term alendronate therapy. Bmc Research Notes 6(): 11-11, 2013

Clinical and biochemical effects of ethane 1 hydroxy 1 1 di phosphonate in pagets disease of bone patterns of response of initial treatment and to long term therapy. Metabolic Bone Disease & Related Research 3(4-5): 301-308, 1981

Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate, hormone replacement therapy, or combination therapy: a three-year, double-blind, placebo-controlled, randomized clinical trial. Journal of Clinical Endocrinology and Metabolism 90(5): 2762-2767, 2005

Treatment of Pagets disease of bone with alendronate 60mg. Journal of Bone & Mineral Research 16(Suppl 1): S302, September, 2001

Clodronate and alendronate, alone or in sequence, in Pagets disease of bone. Calcified Tissue International 52(SUPPL 1): S59, 1993

Long-term elevation of 1,25-dihydroxyvitamin D after short-term intravenous administration of pamidronate in Pagets disease of bone. Journal of Bone & Mineral Research 9(1): 81-85, 1994

Changes in bone mineral density in patients with Pagets disease treated with alendronate. Journal of Bone & Mineral Research 14(SUPPL 1): S541, Sept, 1999